Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte Gayko

NEXT STORY
CarolinasDentist’s Porters Neck Office Welcomes the Addition of Dr. Taylor Berto, DMD
PREV STORY
HOOKIPA Pharma to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ERBA Diagnostics, Inc. Announces the Consummation of the Capital Infusion of $3.5 Million Into the Company

MIAMI LAKES, Fla., Dec. 29, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) ...

author_avatar
NASDAQ Market News

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

author_avatar
NASDAQ Market News

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

Heidelberg, Germany, August 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

author_avatar
NASDAQ Market News